Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Ferraro

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Cancer Treatment and Research|January 4, 2024
Breast Cancer Brain Metastases: Achilles' Heel in Breast Cancer Patients' CareEmanuela Ferraro, Andrew D Seidman
Hematology/Oncology Clinics of North America|November 12, 2025
Neoadjuvant Chemotherapy for Nonmetastatic Breast Cancer: How Response Impacts Locoregional and Adjuvant Systemic Therapy Decision MakingGiacomo Montagna, Emanuela Ferraro, Melissa L Pilewskie
Breast Cancer Research : BCR|August 12, 2021
Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directionsEmanuela Ferraro, Joshua Z Drago, Shanu Modi
Expert Opinion on Pharmacotherapy|September 11, 2019
Evaluating triptorelin as a treatment option for breast cancerEmanuela Ferraro, Dario Trapani, Eleonora Marrucci, et al.
Cancer Treatment and Research|January 4, 2024
Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast CancerAntonio Marra, Dario Trapani, Emanuela Ferraro, et al.
Cancer Treatment Reviews|July 23, 2022
Beyond HER2: Targeting the ErbB receptor family in breast cancerJoshua Z Drago, Emanuela Ferraro, Nour Abuhadra, et al.
Breast (Edinburgh, Scotland)|March 1, 2019
Homologous recombination deficiency in triple negative breast cancerCarmen Belli, Bruno Achutti Duso, Emanuela Ferraro, et al.
Cancer Treatment and Research|January 4, 2024
Innovative Therapeutic Approaches for Patients with HER2-Positive Breast CancerBeatrice Taurelli Salimbeni, Emanuela Ferraro, Luca Boscolo Bielo, et al.
Cancer Treatment Reviews|July 15, 2022
Accelerating drug development in breast cancer: New frontiers for ER inhibitionEmanuela Ferraro, Elaine M Walsh, Jacqueline J Tao, et al.
Expert Review of Anticancer Therapy|August 27, 2019
What therapies are on the horizon for HER2 positive breast cancer?Giulia Viale, Stefania Morganti, Emanuela Ferraro, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Cancer Treatment and Research|January 4, 2024
Breast Cancer Brain Metastases: Achilles' Heel in Breast Cancer Patients' CareEmanuela Ferraro, Andrew D Seidman
Hematology/Oncology Clinics of North America|November 12, 2025
Neoadjuvant Chemotherapy for Nonmetastatic Breast Cancer: How Response Impacts Locoregional and Adjuvant Systemic Therapy Decision MakingGiacomo Montagna, Emanuela Ferraro, Melissa L Pilewskie
Breast Cancer Research : BCR|August 12, 2021
Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directionsEmanuela Ferraro, Joshua Z Drago, Shanu Modi
Expert Opinion on Pharmacotherapy|September 11, 2019
Evaluating triptorelin as a treatment option for breast cancerEmanuela Ferraro, Dario Trapani, Eleonora Marrucci, et al.
Cancer Treatment and Research|January 4, 2024
Mechanisms of Endocrine Resistance in Hormone Receptor-Positive Breast CancerAntonio Marra, Dario Trapani, Emanuela Ferraro, et al.
Cancer Treatment Reviews|July 23, 2022
Beyond HER2: Targeting the ErbB receptor family in breast cancerJoshua Z Drago, Emanuela Ferraro, Nour Abuhadra, et al.
Breast (Edinburgh, Scotland)|March 1, 2019
Homologous recombination deficiency in triple negative breast cancerCarmen Belli, Bruno Achutti Duso, Emanuela Ferraro, et al.
Cancer Treatment and Research|January 4, 2024
Innovative Therapeutic Approaches for Patients with HER2-Positive Breast CancerBeatrice Taurelli Salimbeni, Emanuela Ferraro, Luca Boscolo Bielo, et al.
Cancer Treatment Reviews|July 15, 2022
Accelerating drug development in breast cancer: New frontiers for ER inhibitionEmanuela Ferraro, Elaine M Walsh, Jacqueline J Tao, et al.
Expert Review of Anticancer Therapy|August 27, 2019
What therapies are on the horizon for HER2 positive breast cancer?Giulia Viale, Stefania Morganti, Emanuela Ferraro, et al.
Pageof 4